Stay updated on Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.

Latest updates to the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page
- Check4 days agoChange DetectedThe site version was updated from v3.6.3 to v3.6.4, representing an incremental platform update that does not alter the study information or text on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a minor page update or maintenance revision without changes to the visible content or user functionality.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0, reflecting a small site update to the study record display.SummaryDifference0.1%

- Check48 days agoChange DetectedRecruitment status now indicates no longer looking for participants. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the footer revision updated to v3.6.0 with a formatting tweak to the Intervention/Treatment heading.SummaryDifference0.4%

- Check55 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a small backend/template update rather than a change to the study content.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision metadata on the page was updated to v3.5.4, replacing the previous v3.5.3. This indicates a newer release/version of the page content rather than changes to the study data itself.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Chemo in NSCLC with Progression Clinical Trial page.